| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |